Schizophrenia studies

Trialling CBT for Psychosis in Ordinary Mental Health Services

This study has finished and is no longer accepting participants.

Countries

Sponsor

Melbourne Health

Activa’t per la salut mental! / “Get active!: Increase active participation of people with mental disorders and their families in their recovery processes”

This study isn't currently recruiting.

Countries

Spain

Sponsor

Catalan Federation of Mental Health (Federació Salut Mental Cataluny)

Cluster Controlled study of the Serious Mental Illness Health Improvement Profile [HIP]

This study isn't currently recruiting.

Countries

United Kingdom

Sponsor

Norfolk and Waveney Mental Health NHS Foundation Trust (UK)

A double-blind, randomised, placebo-controlled, parallel group study of GWP42003 as adjunctive therapy in the first line treatment of schizophrenia or related psychotic disorder

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

Countries

United Kingdom, Poland, Romania

Sponsor

GW Research Ltd

A pragmatic randomised double-blind trial of Antipsychotic Treatment of very LAte-onset Schizophrenia-like psychosis: The ATLAS Trial

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

Countries

United Kingdom

Sponsor

King's College London [...] 1. King's College London 2. South London and Maudsley NHS Foundation Trust

Clinical and neuropsychological factors associated with second generation antipsychotic response in patients diagnosed with first episode of early onset schizophrenia spectrum disorders

This study ended early.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

Countries

Spain

Sponsor

FUNDACIÓN SANT JOAN DE DEU

Open-Label, Multicentre, Multiple Dose Study to Evaluate Pharmacokinetics, Safety and Tolerability of Cariprazine in Adolescent Subjects with Schizophrenia, Schizoaffective- and Schizophreniform Di...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

Countries

Bulgaria

Sponsor

Gedeon Richter Plc.

The EXTEND study: evaluating the effectiveness of extended early intervention for psychosis treatment

This study ended early.

Countries

United Kingdom

Sponsor

Pennine Care NHS Foundation Trust

A Double-blind, Placebo-controlled, Relapse Prevention Study of Pimavanserin for the Treatment of Hallucinations and Delusions Associated With Dementia-related Psychosis

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

Countries

France, United Kingdom, Bulgaria, + 5 others

Sponsor

ACADIA Pharmaceuticals Inc.

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Relapse Prevention Study to Evaluate the Safety and Efficacy of KarXT for the Treatment of Psychosis Associated with Alzheimer’s Disease Deme...

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

Countries

France, Bulgaria, Germany, + 3 others

Sponsor

Karuna Therapeutics

A prospective 8 weeks acute phase-IV study investigating efficacy, safety and tolerability of Quetiapine fumarate in 60 drug-naïve first-episode psychosis patients aged 18 to 35 years

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

Countries

Germany

Sponsor

Psychosis Early Detection and Intervention Centre, Department for Psychiatry, UKE Hamburg

A study of the effects of applying Turkington and Kingdon's Normalizing Cognitive Behavioural Therapy Programme with mentally disordered offenders with psychosis

This study isn't currently recruiting.

Countries

United Kingdom

Sponsor

Department of Health